$SFES
SAFEGUARD SCIENTIFICS INC

2017 Q4 Form 10-K Financial Statement

#000008611518000035 Filed on March 07, 2018

View on sec.gov

Income Statement

Concept 2017 Q4 2017 2016 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.900M $17.10M $3.900M
YoY Change 0.0% -8.56% -2.5%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $322.0K
YoY Change -1.83%
% of Gross Profit
Operating Expenses $4.000M $17.20M $3.900M
YoY Change 2.56% -8.02% 0.0%
Operating Profit -$3.940M -$17.13M -$3.928M
YoY Change 0.31% -8.35% -0.76%
Interest Expense -$14.80M -$71.60M -$17.80M
YoY Change -16.85% 3668.42% 74.51%
% of Operating Profit
Other Income/Expense, Net -$120.0K -$339.0K $64.00K
YoY Change -287.5% -79.85% -176.19%
Pretax Income -$18.73M -$88.57M -$21.70M
YoY Change -13.7% 297.86% 52.06%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$18.73M -$88.57M -$21.70M
YoY Change -13.7% 297.86% 52.06%
Net Earnings / Revenue
Basic Earnings Per Share -$0.91 -$4.34 -$1.07
Diluted Earnings Per Share -$0.91 -$4.34 -$1.07
COMMON SHARES
Basic Shares Outstanding 20.41M shares 20.43M shares 20.24M shares
Diluted Shares Outstanding 20.43M shares

Balance Sheet

Concept 2017 Q4 2017 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $25.25M $29.00M $30.40M
YoY Change -16.94% -4.61% -52.43%
Cash & Equivalents $20.75M $20.80M $22.06M
Short-Term Investments $4.500M $8.200M $8.400M
Other Short-Term Assets $4.600M $4.600M $2.100M
YoY Change 119.05% 119.05% -63.79%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $33.61M $33.60M $32.55M
YoY Change 3.25% 3.07% -53.28%
LONG-TERM ASSETS
Property, Plant & Equipment $1.513M $1.500M $1.873M
YoY Change -19.22% -21.05% -12.68%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $108.1M $134.7M $154.7M
YoY Change -30.11% -29.4% 1.86%
Other Assets $316.0K $6.700M $296.0K
YoY Change 6.76% 1.52% -71.46%
Total Long-Term Assets $142.9M $142.9M $199.3M
YoY Change -28.31% -28.26% 6.47%
TOTAL ASSETS
Total Short-Term Assets $33.61M $33.60M $32.55M
Total Long-Term Assets $142.9M $142.9M $199.3M
Total Assets $176.5M $176.5M $231.8M
YoY Change -23.88% -23.86% -9.74%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $155.0K $200.0K $140.0K
YoY Change 10.71% 100.0% -51.72%
Accrued Expenses $1.851M $5.200M $2.223M
YoY Change -16.73% -8.77% -20.29%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $40.49M $40.50M $0.00
YoY Change
Total Short-Term Liabilities $45.81M $45.80M $5.861M
YoY Change 681.64% 676.27% -8.66%
LONG-TERM LIABILITIES
Long-Term Debt $45.30M $45.30M $52.60M
YoY Change -13.88% -13.88% 1.74%
Other Long-Term Liabilities $3.535M $3.500M $3.630M
YoY Change -2.62% -2.78% -8.45%
Total Long-Term Liabilities $3.535M $48.80M $3.630M
YoY Change -2.62% -13.17% -8.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $45.81M $45.80M $5.861M
Total Long-Term Liabilities $3.535M $48.80M $3.630M
Total Liabilities $94.67M $94.70M $62.05M
YoY Change 52.56% 52.5% 1.16%
SHAREHOLDERS EQUITY
Retained Earnings -$715.5M -$626.9M
YoY Change 14.13% 3.75%
Common Stock $814.7M $818.2M
YoY Change -0.43% -0.17%
Preferred Stock
YoY Change
Treasury Stock (at cost) $17.31M $21.06M
YoY Change -17.82% 7.62%
Treasury Stock Shares 999.0K shares 1.209M shares
Shareholders Equity $81.80M $81.80M $169.8M
YoY Change
Total Liabilities & Shareholders Equity $176.5M $176.5M $231.8M
YoY Change -23.88% -23.86% -9.74%

Cashflow Statement

Concept 2017 Q4 2017 2016 Q4
OPERATING ACTIVITIES
Net Income -$18.73M -$88.57M -$21.70M
YoY Change -13.7% 297.86% 52.06%
Depreciation, Depletion And Amortization $322.0K
YoY Change -1.83%
Cash From Operating Activities -$5.300M -$20.81M -$4.600M
YoY Change 15.22% 11.49% 27.78%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 -$300.0K
YoY Change -100.0% -100.0% -80.0%
Acquisitions
YoY Change
Other Investing Activities -$8.200M $0.00 -$19.20M
YoY Change -57.29% -100.0% -14.67%
Cash From Investing Activities -$8.200M -$10.13M -$19.50M
YoY Change -57.95% -150.48% -18.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.000K
YoY Change -99.98%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -100.0K $29.63M 0.000
YoY Change -606.93% -100.0%
NET CHANGE
Cash From Operating Activities -5.300M -$20.81M -4.600M
Cash From Investing Activities -8.200M -$10.13M -19.50M
Cash From Financing Activities -100.0K $29.63M 0.000
Net Change In Cash -13.60M -$1.307M -24.10M
YoY Change -43.57% -70.59% -21.75%
FREE CASH FLOW
Cash From Operating Activities -$5.300M -$20.81M -$4.600M
Capital Expenditures $0.00 $0.00 -$300.0K
Free Cash Flow -$5.300M -$20.81M -$4.300M
YoY Change 23.26% 13.93% 104.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017 dei Amendment Flag
AmendmentFlag
false
CY2017 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2017 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2017 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
CY2017 dei Document Period End Date
DocumentPeriodEndDate
2017-12-31
CY2017 dei Document Type
DocumentType
10-K
CY2017 dei Entity Central Index Key
EntityCentralIndexKey
0000086115
CY2018Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
20566680 shares
CY2017 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2017 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2017Q2 dei Entity Public Float
EntityPublicFloat
237111560 USD
CY2017 dei Entity Registrant Name
EntityRegistrantName
SAFEGUARD SCIENTIFICS INC
CY2017 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2017 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2017 dei Trading Symbol
TradingSymbol
SFE
CY2017Q4 sfe Cash Liabilityfor Performance Based Units
CashLiabilityforPerformanceBasedUnits
0 USD
CY2017Q4 sfe Equity Method Investment Assets Exceed Carrying Value Of Investment
EquityMethodInvestmentAssetsExceedCarryingValueOfInvestment
77500000 USD
CY2001Q4 sfe Future Annual Payment To Chairman And Chief Executive Officer
FutureAnnualPaymentToChairmanAndChiefExecutiveOfficer
650000 USD
CY2017Q4 sfe Impaired Loans Carrying Amount
ImpairedLoansCarryingAmount
0 USD
CY2017 sfe Loan Impairment Charge
LoanImpairmentCharge
15700000 USD
CY2017Q4 sfe Net Operating Loss Carryforwards Expiring In Year Four
NetOperatingLossCarryforwardsExpiringInYearFour
3728000 USD
CY2017Q4 sfe Net Operating Loss Carryforwards Expiring In Year One
NetOperatingLossCarryforwardsExpiringInYearOne
0 USD
CY2017Q4 sfe Net Operating Loss Carryforwards Expiring In Year Thereafter
NetOperatingLossCarryforwardsExpiringInYearThereafter
250572000 USD
CY2017Q4 sfe Net Operating Loss Carryforwards Expiring In Year Three
NetOperatingLossCarryforwardsExpiringInYearThree
0 USD
CY2017Q4 sfe Net Operating Loss Carryforwards Expiring In Year Two
NetOperatingLossCarryforwardsExpiringInYearTwo
0 USD
CY2015 sfe Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments
OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments
-246000 USD
CY2016 sfe Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments
OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments
-185000 USD
CY2017 sfe Other Comprehensive Income Loss Shareof Other Comprehensive Income Lossof Equity Method Investments
OtherComprehensiveIncomeLossShareofOtherComprehensiveIncomeLossofEquityMethodInvestments
318000 USD
CY2017Q4 sfe Partner Companies Not Consolidated In Financial Statements
PartnerCompaniesNotConsolidatedInFinancialStatements
25 partner_company
CY2017Q4 sfe Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Award Vesting Types
SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofAwardVestingTypes
2 vesting_type
CY2017 sfe Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Asset Provisional Income Tax Expense Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetProvisionalIncomeTaxExpenseBenefit
82500000 USD
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
140000 USD
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
155000 USD
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2223000 USD
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1851000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-431000 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-113000 USD
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
816016000 USD
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
812536000 USD
CY2017 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
-826000 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1611000 USD
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2394000 USD
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1138000 USD
CY2016Q4 us-gaap Advances To Affiliate
AdvancesToAffiliate
25142000 USD
CY2017Q4 us-gaap Advances To Affiliate
AdvancesToAffiliate
22506000 USD
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1611000 USD
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2394000 USD
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1138000 USD
CY2015 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1472000 USD
CY2016 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1604000 USD
CY2017 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2542000 USD
CY2016 us-gaap Asset Impairment Charges
AssetImpairmentCharges
2360000 USD
CY2017 us-gaap Asset Impairment Charges
AssetImpairmentCharges
216000 USD
CY2016Q4 us-gaap Assets
Assets
231828000 USD
CY2017Q4 us-gaap Assets
Assets
176464000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
32551000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
33608000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22058000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20751000 USD
CY2017Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
25200000 USD
CY2014Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
111897000 USD
CY2015Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
32838000 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
28394000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27087000 USD
CY2015 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-79059000 USD
CY2016 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-4444000 USD
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1307000 USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
3400000 shares
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
83333000 shares
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
83333000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21573000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21573000 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
2157000 USD
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
2157000 USD
CY2016Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
52560000 USD
CY2017Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 USD
CY2016Q4 us-gaap Cost Method Investments
CostMethodInvestments
3662000 USD
CY2017Q4 us-gaap Cost Method Investments
CostMethodInvestments
4096000 USD
CY2016 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
3900000 USD
CY2017 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
10800000 USD
CY2016Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
95134000 USD
CY2017Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
69751000 USD
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
182165000 USD
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
130436000 USD
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1310000 USD
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
967000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
82775000 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
58138000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1763000 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
814000 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1183000 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
766000 USD
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
182165000 USD
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
130436000 USD
CY2015 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
190000 USD
CY2016 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
328000 USD
CY2017 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
322000 USD
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.85
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.76
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.92
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.18
CY2016Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.07
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.09
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.08
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.43
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.91
CY2017Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.91
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.34
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.85
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.76
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.70
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.18
CY2016Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.07
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.09
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.08
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.43
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.91
CY2017Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.91
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.34
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.347
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.344
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.584
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.000
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.000
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.932
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
-0.002
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
-0.004
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
-0.002
CY2015 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.001
CY2016 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.002
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3498000 USD
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3321000 USD
CY2016Q4 us-gaap Equity Method Investments
EquityMethodInvestments
154666000 USD
CY2017Q4 us-gaap Equity Method Investments
EquityMethodInvestments
108089000 USD
CY2015 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2016 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2017 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2015 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
2914000 USD
CY2016 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
424000 USD
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17554000 USD
CY2016Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5228000 USD
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4849000 USD
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4687000 USD
CY2016Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3928000 USD
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18692000 USD
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4947000 USD
CY2017Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4486000 USD
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3758000 USD
CY2017Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3940000 USD
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17131000 USD
CY2017Q4 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
3800000 USD
CY2016Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
8384000 USD
CY2017Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
4452000 USD
CY2016Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
7302000 USD
CY2017Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
0 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-59524000 USD
CY2016Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15452000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
38976000 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24085000 USD
CY2016Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21701000 USD
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22262000 USD
CY2017Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-22097000 USD
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-29097000 USD
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18650000 USD
CY2017Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18728000 USD
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-88572000 USD
CY2015 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-39599000 USD
CY2016Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-9495000 USD
CY2016Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
43794000 USD
CY2016Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-16345000 USD
CY2016Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-17283000 USD
CY2016 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
671000 USD
CY2017Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-17002000 USD
CY2017Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-23497000 USD
CY2017Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-12874000 USD
CY2017Q4 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-12985000 USD
CY2017 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-66358000 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2016Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2016Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2017Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2017Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
923000 USD
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1521000 USD
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
3560000 USD
CY2015 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
43000 USD
CY2016 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-215000 USD
CY2017 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
628000 USD
CY2015 us-gaap Interest Expense Debt
InterestExpenseDebt
4523000 USD
CY2016Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
1149000 USD
CY2016Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
1155000 USD
CY2016Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
1161000 USD
CY2016Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
1169000 USD
CY2016 us-gaap Interest Expense Debt
InterestExpenseDebt
4634000 USD
CY2017Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
1198000 USD
CY2017Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
2112000 USD
CY2017Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
2643000 USD
CY2017Q4 us-gaap Interest Expense Debt
InterestExpenseDebt
2667000 USD
CY2017 us-gaap Interest Expense Debt
InterestExpenseDebt
8620000 USD
CY2015 us-gaap Interest Paid
InterestPaid
2900000 USD
CY2016 us-gaap Interest Paid
InterestPaid
2900000 USD
CY2017 us-gaap Interest Paid
InterestPaid
5000000 USD
CY2015 us-gaap Investment Income Interest
InvestmentIncomeInterest
1935000 USD
CY2016Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
420000 USD
CY2016Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
527000 USD
CY2016Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
513000 USD
CY2016Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
615000 USD
CY2016 us-gaap Investment Income Interest
InvestmentIncomeInterest
2075000 USD
CY2017Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
801000 USD
CY2017Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1087000 USD
CY2017Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1004000 USD
CY2017Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
984000 USD
CY2017 us-gaap Investment Income Interest
InvestmentIncomeInterest
3876000 USD
CY2016Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
183470000 USD
CY2017Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
134691000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
62051000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
94668000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
231828000 USD
CY2016Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
0 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
176464000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5861000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
45812000 USD
CY2017Q4 us-gaap Loans Receivable Net
LoansReceivableNet
6300000 USD
CY2016Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2017Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
40485000 USD
CY2017Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
45321000 USD
CY2017Q4 us-gaap Marketable Securities
MarketableSecurities
4500000 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4321000 USD
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5844000 USD
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29625000 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-56989000 USD
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
20061000 USD
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10127000 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17749000 USD
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18661000 USD
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-20805000 USD
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-17554000 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5228000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4849000 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4687000 USD
CY2016Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-3928000 USD
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-18692000 USD
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4947000 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-4486000 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3758000 USD
CY2017Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-3940000 USD
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-17131000 USD
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
5047000 USD
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
593000 USD
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
598000 USD
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
603000 USD
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
605000 USD
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
2648000 USD
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000 USD
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000 USD
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000 USD
CY2017Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
254300000 USD
CY2017Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
254000000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
296000 USD
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
316000 USD
CY2015 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-59770000 USD
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-22447000 USD
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-88254000 USD
CY2015 us-gaap Other Income
OtherIncome
57000 USD
CY2016 us-gaap Other Income
OtherIncome
254000 USD
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3630000 USD
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3535000 USD
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
217000 USD
CY2016Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
659000 USD
CY2016Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2405000 USD
CY2016Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
64000 USD
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1682000 USD
CY2017Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
249000 USD
CY2017Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-89000 USD
CY2017Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-379000 USD
CY2017Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-120000 USD
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-339000 USD
CY2015 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
15208000 USD
CY2016 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
27967000 USD
CY2017 us-gaap Payments For Advance To Affiliate
PaymentsForAdvanceToAffiliate
22867000 USD
CY2015 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2016 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-64000 USD
CY2017 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2015 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4997000 USD
CY2016 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5389000 USD
CY2017 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2015 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2016 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2017 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
5696000 USD
CY2015 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
CY2016 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
460000 USD
CY2017 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
223000 USD
CY2015 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
70186000 USD
CY2016 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
52431000 USD
CY2017 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
15101000 USD
CY2015 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
29755000 USD
CY2016 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
21194000 USD
CY2017 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
0 USD
CY2015 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1856000 USD
CY2016 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
432000 USD
CY2017 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
0 USD
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2109000 USD
CY2017Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4644000 USD
CY2015 us-gaap Proceeds From Collection Of Advance To Affiliate
ProceedsFromCollectionOfAdvanceToAffiliate
1318000 USD
CY2016 us-gaap Proceeds From Collection Of Advance To Affiliate
ProceedsFromCollectionOfAdvanceToAffiliate
1741000 USD
CY2017 us-gaap Proceeds From Collection Of Advance To Affiliate
ProceedsFromCollectionOfAdvanceToAffiliate
0 USD
CY2015 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
25058000 USD
CY2016 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
73965000 USD
CY2017 us-gaap Proceeds From Divestiture Of Businesses And Interests In Affiliates
ProceedsFromDivestitureOfBusinessesAndInterestsInAffiliates
16604000 USD
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
676000 USD
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5000 USD
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-1000 USD
CY2015 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
CY2016 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
CY2017 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
50000000 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
17100000 USD
CY2015 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
CY2016 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
100000 USD
CY2017 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
CY2015 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
33640000 USD
CY2016 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
46315000 USD
CY2017 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
11237000 USD
CY2015 us-gaap Profit Loss
ProfitLoss
-59524000 USD
CY2016Q1 us-gaap Profit Loss
ProfitLoss
-15452000 USD
CY2016Q2 us-gaap Profit Loss
ProfitLoss
38976000 USD
CY2016Q3 us-gaap Profit Loss
ProfitLoss
-24085000 USD
CY2016Q4 us-gaap Profit Loss
ProfitLoss
-21701000 USD
CY2016 us-gaap Profit Loss
ProfitLoss
-22262000 USD
CY2017Q1 us-gaap Profit Loss
ProfitLoss
-22097000 USD
CY2017Q2 us-gaap Profit Loss
ProfitLoss
-29097000 USD
CY2017Q3 us-gaap Profit Loss
ProfitLoss
-18650000 USD
CY2017Q4 us-gaap Profit Loss
ProfitLoss
-18728000 USD
CY2017 us-gaap Profit Loss
ProfitLoss
-88572000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1873000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1513000 USD
CY2001Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
26500000 USD
CY2015 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
CY2016 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
CY2017 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
14455000 USD
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
6336000 USD
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
6336000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-626904000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-715476000 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
1611000 USD
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
2394000 USD
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
1138000 USD
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
900000 USD
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
900000 USD
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000 USD
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.25
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.29
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.36
CY2015 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
7.14
CY2016 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
9.83
CY2017 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
9.83
CY2015 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
19.95
CY2016 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
19.95
CY2017 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
19.95
CY2015 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2016 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2017 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2015 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
158000 USD
CY2016 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
32000 USD
CY2017 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-38000 USD
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
676000 USD
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-318000 USD
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-1000 USD
CY2015 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
4997000 USD
CY2016 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
5389000 USD
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
257827000 USD
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
195505000 USD
CY2016Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
169777000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
81796000 USD
CY2017 us-gaap Trading Gains Losses
TradingGainsLosses
-493000 USD
CY2016Q4 us-gaap Trading Securities
TradingSecurities
0 USD
CY2017Q4 us-gaap Trading Securities
TradingSecurities
3761000 USD
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1209000 shares
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
999000 shares
CY2016Q4 us-gaap Treasury Stock Value
TreasuryStockValue
21061000 USD
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
17308000 USD
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20874000 shares
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20343000 shares
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20430000 shares
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20874000 shares
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20343000 shares
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20430000 shares
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Accounting Estimates</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the Consolidated Financial Statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and judgments that affect amounts reported in the financial statements and accompanying notes. Actual results may differ from these estimates. These estimates include the evaluation of the recoverability of the Company&#8217;s ownership interests in and advances to partner companies, income taxes, stock-based compensation and commitments and contingencies. Management evaluates its estimates on an ongoing basis using historical experience and other factors, including the current economic environment, which management believes to be reasonable under the circumstances.</font></div><div style="line-height:120%;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div><div style="line-height:120%;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain amounts recorded to reflect the Company&#8217;s share of income or losses of partner companies accounted for under the equity method are based on unaudited results of operations of those companies and may require adjustments in the future when audits of these entities&#8217; financial statements are completed. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">It is reasonably possible that the Company&#8217;s accounting estimates with respect to the ultimate recoverability of the carrying value of the Company&#8217;s ownership interests in and advances to partner companies could change in the near term and that the effect of such changes on the financial statements could be material. At December&#160;31, </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;">, the Company believes the carrying value of the Company&#8217;s ownership interests in and advances to partner companies is not impaired, although there can be no assurance that the Company&#8217;s future results will confirm this assessment, that a significant write-down or write-off will not be required in the future or that a significant loss will not be recorded in the future upon the sale of a company.</font></div></div>

Files In Submission

Name View Source Status
0000086115-18-000035-index-headers.html Edgar Link pending
0000086115-18-000035-index.html Edgar Link pending
0000086115-18-000035.txt Edgar Link pending
0000086115-18-000035-xbrl.zip Edgar Link pending
chart-b01c82f6b10c5ead934.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
sfe-20171231.xml Edgar Link completed
sfe-20171231.xsd Edgar Link pending
sfe-20171231_cal.xml Edgar Link unprocessable
sfe-20171231_def.xml Edgar Link unprocessable
sfe-20171231_lab.xml Edgar Link unprocessable
sfe-20171231_pre.xml Edgar Link unprocessable
sfe201710k.htm Edgar Link pending
sfe201710kex141.htm Edgar Link pending
sfe201710kex211.htm Edgar Link pending
sfe201710kex231.htm Edgar Link pending
sfe201710kex311.htm Edgar Link pending
sfe201710kex312.htm Edgar Link pending
sfe201710kex321.htm Edgar Link pending
sfe201710kex322.htm Edgar Link pending
Show.js Edgar Link pending